Precede Biosciences
Precede Biosciences: Revolutionizing precision medicine with minimally invasive diagnostics and personalized therapies.
Founded
2005Precede Biosciences: Revolutionizing precision medicine with minimally invasive diagnostics and personalized therapies.
Precede Biosciences, founded in Boston, Massachusetts, is dedicated to advancing precision medicine through innovative diagnostics and personalized therapies. Their core mission is to enhance drug development success rates and ensure that patients receive quick, minimally invasive diagnoses and treatments tailored to their specific biological conditions. By leveraging simple blood draws, Precede Biosciences aims to break down barriers in medical diagnostics and contribute to a future where precision medicine is accessible to all.
Notable figures associated with Precede Biosciences include leading scientists and healthcare professionals committed to transforming patient care. The company has attracted significant interest from investors focused on cutting-edge medical technologies. Key achievements include the development of proprietary diagnostic tools that have shown promise in clinical trials, positioning Precede Biosciences as a pioneer in the field. Their impact is seen in the potential to significantly improve patient outcomes and streamline the drug development process, making precision medicine a reality for more individuals.
Companies similar to Precede Biosciences include Precision Biologics, Path BioAnalytics, Amplified Sciences and Precision Theranostics.
Precede Biosciences was founded in 2005.
Precede Biosciences' headquarters is located in Boston, MA, US.
Precede Biosciences' most recent funding round was for $57M (USD) in October 2023.
As of Oct 5, 2023, Precede Biosciences has raised a total of $57M (USD).
Precede Biosciences has 30 employees as of Feb 4, 2024.
